for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. Raltegravir Tablets USP, 600 mg are indicated ...

City-level hospitals purchase 14 large medical appliances, all from leading international companies, at the CIIE on Friday alongside cooperation on infectious disease management.

Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

Opens in a new tab or window Share on X ... High persistence and high adherence were observed in this population. HIV testing ...

José Benitez, the new Philadelphia FIGHT CEO, aims to expand the organization's services and increase community access.

The country’s successful rollout of HIV anti-retroviral drugs has lulled many into a false sense of security around ...

These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss ... The ...

If approved, donidalorsen would be a first-in-class RNA-targeted medicine for hereditary angioedema. The agency’s goal date ...

Michael Weinstein, AHF President, sits at the center of two dueling initiatives, including one whose $170 million in total spending makes it the country’s most expensive this year and among the most ...

David Munar, who was appointed CEO in April, says the provider is on the "right track," but it will take time.